Med J Armed Forces India. 2016 Apr;72(2):140-4. doi: 10.1016/j.mjafi.2016.02.006. Epub 2016 Apr 18.
Prevalence of occult hepatitis B infection in patients visiting tertiary care hospital.
Medical journal, Armed Forces India
A K Sood, Chetan Pangotra, Manish Manrai
Affiliations
Affiliations
- Senior Adviser (Medicine and Gastroenterology), Command Hospital (Western Command), C/O 56 APO, India.
- Graded Specialist (Medicine), 167 Military Hospital, C/O 56 APO, India.
- Classified Specialist (Medicine and Gastroenterologist), Army Hospital (R&R), Delhi Cantt 110010, India.
PMID: 27257324
PMCID: PMC4878925 DOI: 10.1016/j.mjafi.2016.02.006
Abstract
BACKGROUND: To study the prevalence of occult hepatitis B virus infection (OBI) in a tertiary care hospital.
METHODS: 50 HBsAg negative individuals, each amongst blood donors, alcohol dependence syndrome (ADS), alcoholic cirrhotics, hepatitis C virus (HCV)/cryptogenic cirrhotics, end-stage renal disease (ESRD) on maintenance haemodialysis for one year, all malignancies prior to chemotherapy and HIV positive patients were evaluated for anti-HBc total antibody, and blood hepatitis B virus (HBV) DNA amplification in those tested positive.
RESULTS: A total of 60/369 (16.2%) individuals were anti-HBc total positive, 13/50 (26%) of HCV/cryptogenic cirrhotics, 13/52 (25%) of HIV positive, 10/50 (20%) of patients with malignancy, 10/51 (19.6%) and 7/59 (11.9%) of alcoholic cirrhotics and ADS respectively had intermediate prevalence, while, blood donors 5/55 (9.1%), ESRD patients 2/52 (3.8%) had low prevalence. 12 patients (20% of all anti-HBc total positive cases) were HBV DNA positive, 5 HCV cirrhotics (10% of total HCV/cryptogenic), 4 HIV positive (7.69%), 1 each of ADS (1.69%), alcoholic cirrhotics (1.96%) and malignancy group (2%). Blood donors and ESRD patients were negative for HBV DNA.
CONCLUSION: HBV DNA amplification may under diagnose OBI and anti-HBc total positivity may be a better surrogate marker. Nucleic acid testing of blood donors, however is preferred, especially in high endemic areas. OBI must be looked for in cirrhotics, HIV infection, and patients with cancers prior to chemotherapy, as they may contribute to morbidity in them.
Keywords: Cirrhosis; HIV infection; Hepatitis B antibodies; Neoplasms; Occult hepatitis B infection
References
- Blood Transfus. 2008 Jan;6(1):46-50 - PubMed
- Transfusion. 2009 Oct;49(10):2214-20 - PubMed
- AIDS Res Hum Retroviruses. 2005 Nov;21(11):922-6 - PubMed
- Indian J Med Res. 2010 Sep;132:312-7 - PubMed
- World J Gastroenterol. 2011 Apr 21;17(15):1927-38 - PubMed
- Leuk Lymphoma. 2015;56(10):2841-6 - PubMed
- J Clin Virol. 2006 May;36 Suppl 1:S33-44 - PubMed
- J Hepatol. 2014 Sep;61(3):688-9 - PubMed
- Transfusion. 2007 Jan;47(1):74-9 - PubMed
- J Trop Med. 2014;2014:796121 - PubMed
- J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):309-14 - PubMed
- Liver Int. 2012 Feb;32(2):231-40 - PubMed
- World J Hepatol. 2013 Feb 27;5(2):64-73 - PubMed
- Gut. 2000 Sep;47(3):429-35 - PubMed
- Hepat Mon. 2012 Apr;12(4):253-8 - PubMed
- J Gastroenterol Hepatol. 2010 May;25(5):864-71 - PubMed
- J Hepatol. 2001 Mar;34(3):447-54 - PubMed
- J Hepatol. 2005 Mar;42(3):302-8 - PubMed
- Br J Haematol. 1999 Oct;107(1):186-95 - PubMed
- J Med Virol. 1999 Jul;58(3):201-7 - PubMed
- Ther Apher Dial. 2013 Jun;17(3):289-92 - PubMed
- N Engl J Med. 1999 Jul 1;341(1):22-6 - PubMed
- Transfusion. 2007 Jul;47(7):1197-205 - PubMed
- Eur J Clin Microbiol Infect Dis. 2003 Feb;22(2):92-8 - PubMed
- Transfusion. 2005 Aug;45(8):1247-57 - PubMed
Publication Types